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Abstract
Introduction: Magnetic resonance imaging (MRI) has been proven capable of showing inflammatory and structural
changes in patients with spondyloarthritis (SpA) and has become widely used in the diagnosis of SpA. Despite this,
no systematic reviews evaluate the diagnostic utility of MRI for SpA. Therefore, the objective of this systematic
review was to determine the evidence for the utility of MRI in the clinical diagnosis of SpA. The aims were to
identify which MRI findings are associated with the diagnosis of SpA and to quantify this association.
Methods: MEDLINE and EMBASE were electronically searched. Inclusion criteria were cross-sectional or longitudinal
case-control or cohort MRI studies. The studies required a group with either SpA or inflammatory back pain (IBP)
and a non-case group without SpA or IBP. Each group required a minimum of 20 participants. The included articles
had to report results containing raw numbers suitable for the construction of two-by-two tables or report results
by sensitivity and specificity for cross-sectional studies or odds ratios, relative risk ratios, or likelihood ratios for
longitudinal studies. Method quality was assessed by using criteria based on the QUADAS tool.
Results: In total, 2,395 articles were identified in MEDLINE and EMBASE before November 2011. All articles were
reviewed by title and abstract. Seventy-seven articles were reviewed by full text, and 10 met the inclusion criteria.
Two were considered of high quality: one evaluated the sacroiliac joints, and the other, the spine. Because of the
small number of high-quality studies, a meta-analysis was not performed. The two high-quality studies found a
positive association between MRI findings (bone marrow edema, erosions, fat infiltrations, global assessment of
sacroiliitis, and ankylosis) and the diagnosis of IBP and SpA.
Conclusion: In this review, several MRI findings were found to be associated with SpA. However, because of the
small number of high-quality studies, the evidence for the utility of MRI in the diagnosis of SpA must be
considered limited. Therefore, caution should be taken to ensure that inflammatory and structural MRI findings are
not interpreted as being more specific for SpA than is supported by research.
Introduction
Spondyloarthritis (SpA) is a rheumatologic disease that
comprises the different disease entities of ankylosing
spondylitis (AS), reactive arthritis, psoriasis arthritis,
spondyloarthritis associated with inflammatory bowel
disease, and undifferentiated spondyloarthritis. The
main symptoms are chronic back pain, associated with
extraspinal manifestations and particular laboratory find-
ings. It usually emerges in the second or third decade of
life and, although it is relatively rare, the prevalence
being about 0.25% to 1% in the European population
[1], it is a health condition worthy of attention because
it can be debilitating for those affected, especially if
undiagnosed.
With the introduction of tumor necrosis factor-a inhi-
bitors in the treatment of preradiographic SpA [2,3], the
interest in early and precise diagnosis has increased.
However, the early diagnosis of SpA is often difficult. In
chronic back pain patients, the most common diagnosis
is nonspecific low-back pain (NSLBP), and SpA is esti-
mated to contribute only 5% of the causes of back pain in
primary care patients [4]. Even though plain radiography
can detect structural changes of the spine and sacroiliac
joints (SIJs), patients often have symptoms for several
years before these changes become evident [5].
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Over the past three decades, magnetic resonance ima-
ging (MRI) has proven capable of detecting preradio-
graphic inflammatory lesions seen in SpA patients [6,7],
and optimism exists regarding the opportunities MRI can
offer for early diagnosis of SpA. This is indicated by the
inclusion of MRI of the SIJ in the criteria for axial SpA
developed by the Assessment of SpondyloArthritis inter-
national Society (ASAS) in 2009 [8]. However, to our
knowledge, no systematic critical literature reviews have
addressed the utility of MRI in the diagnosis of SpA.
The objective of this systematic critical review was
therefore to determine the level of evidence for the utility
of MRI in relation to the clinical diagnosis of SpA. The
specific aims of this review were to identify which MRI
findings are associated with the diagnosis of SpA and to
quantify this association.
Methods
Search method for identification of studies
Searches were made in the MEDLINE and EMBASE data-
bases for articles published before November 2011. The
following search terms were used as free text and MeSH
terms: “magnetic resonance imaging,” “spondyloarthritis,”
“ankylosing spondylitis,” “sacroiliitis,” “psoriasis arthritis,”
“reactive arthritis,” “arthritis and inflammatory bowel dis-
ease,” and “inflammatory back pain.” Different forms of
spelling and synonyms for each term were also used.
Inclusion criteria for considering studies for this review
Types of studies
Prospective and retrospective case-control or cohort stu-
dies were accepted. Both cross-sectional and longitudinal
studies were accepted. Articles in English, German,
French, Norwegian, Swedish, and Danish were included,
as these were the linguistic capabilities of the author team.
Study subjects
Studies were required to include a group of cases with
the clinical diagnosis of SpA or inflammatory back pain
(IBP) and a group of noncases without SpA or IBP,
respectively. Each case and noncase group had to contain
more than 20 participants. The criteria for sample size
were set arbitrarily to reduce the risk of imprecise esti-
mates with very wide confidence intervals (CIs). The
mean age of the study sample had to be older than 18
and younger than 65 years.
Index test
The index test under evaluation was MRI of the axial ske-
leton. The field strength had to be a minimum of 1.5 Tesla
to secure a minimal standard of the imaging. No other
limitations were set for the technical equipment used, and
all types of MRI sequences were accepted.
Target condition
The target condition was either SpA, one of the disease
subgroups of SpA (AS, psoriasis arthritis, reactive
arthritis, arthritis associated with IBP, or undifferen-
tiated SpA) or IBP.
Reference standard
The reference standard was the clinical diagnosis of one
of the target conditions defined by a diagnostic criterion
or by expert opinion. The diagnosis had to have been
made from clinical information. Information from plain
radiography and serologic testing was accepted as part of
the diagnosis.
Results presentation
Articles were included only if they reported one of the
following: Results containing raw numbers suitable for
the construction of two-by-two tables, for cross-sec-
tional studies if they reported results by sensitivity and
specificity, and for longitudinal studies if they reported
odds ratios, relative risk ratios, or likelihood ratios.
Data collection and analysis
Selection of studies
Initially, the first author reviewed the titles and abstracts of
the search results for identification of relevant articles to be
retrieved in full text. The full texts were screened for rele-
vance, and double publications were excluded at this stage.
Subsequently, the identified articles were reviewed in full
text for data extraction by the first and third authors.
Data extraction and management
The first and third authors independently extracted the
data from the relevant articles according to a check-list
specifying the information needed regarding the following
factors: (a) study sample(s), (b) clinical diagnosis, (c) MRI
findings, (d) MRI technique, (e) MRI evaluation, (f) data
analysis, and (g) results. In case of disagreements, consen-
sus was reached through discussion.
Assessment of methodologic quality
The quality of the included articles was assessed with a
set of quality criteria, based on the QUADAS tool [9].
The quality assessment was subdivided into four topics:
(a) study sampling, (b) clinical diagnosis, (c) MRI eva-
luation, and (d) data analysis and results. Each item was
rated from 0 to 2, resulting in a maximum of 8 points
per article (Table 1). For longitudinal studies, the
reporting on drop-out rates and reasons for dropping
out were to be assessed.
The assessment was performed independently by the first
and the third authors. Any disagreements in the assess-
ments were settled by consensus and discussion with the
second author. Articles with a quality score of more than 5
points were arbitrarily regarded as high-quality studies.
Only results from high-quality studies were further
reviewed.
Statistical analysis and data synthesis
Sensitivity and specificity were retrieved from the article
where possible and calculated from raw data when not
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reported in the article. The Wilson score method with-
out continuity correction was used to calculate the 95%
CI, if it were not reported in the article. Meta-analysis
was planned to be performed on homogeneous high-
quality studies, but was not performed because of insuf-
ficient data.
Results
Description of studies
In all, 1,336 articles were found in MEDLINE, and
2,359, in EMBASE. After elimination of duplicates,
2,395 articles were reviewed by title and abstract, and 76
articles were identified for assessment in full text. After
full-text review, nine cross-sectional articles met the
inclusion criteria [10-18] (Figure 1). No longitudinal stu-
dies met the inclusion criteria. Reasons for exclusion of
articles reviewed in full text are presented in Table 2 for
articles on cross-sectional studies and in Table 3 for
articles on longitudinal studies.
Description of included articles
The nine articles meeting the inclusion criteria were based
on eight study samples and were published between 1995
and 2010 [10-18]. Two studies were conducted on the
same study population [17,18]. Seven of the nine articles
were designed to address the diagnostic utility of MRI in
the diagnosis of either AS, SpA, or IBP. One article com-
pared ultrasound with MRI in the diagnosis of IBP [11],
and one article evaluated referral recommendations [12].
Five studies reported results for the SIJ [10-14], and four,
the results for the spine; one of the lumbar spine [15] and
three of the whole spine [16-18]. The sample sizes varied
from 85 to 187 participants. The diagnoses under evalua-
tion were AS [10,12-16], SpA [10,12,14,17,18], and IBP
[11,13,16]. The groups of noncases were no LBP
[11,13,16-18] and/or noninflammatory low-back pain,
such as NSLBP, degenerative arthritis, cancer, and LBP of
Table 1 Quality scores for the articles on MRI and SpA fulfilling the inclusion criteria
Bollow
et al.
(1995) [10]
Klauser
et al.
(2004) [11]
Brandt
et al.
(2007) [12]
Weber
et al.
(2010) [13]
Wick et al.
(2010)
[14]
Kim et al.
(2008)
[15]
Weber
et al.
(2009) [16]
Bennett
et al. (2009)
[17]
Bennett
et al. (2009)
[18]
Study sampling (0-1) 1 0 1 2 1 1 2 1 1
Diagnosis (0-1) 1 0 0 1 0 1 1 0 0
MRI evaluation (0-1) 0 0 0 2 2 1 2 2 1
Data analysis and
presentation of
results (0-1)
0 1 1 2 0 1 2 1 1
Total (0-8) 2 1 2 7 3 4 7 4 3
Diagnosis assessed on IBP or SpA diagnosed by criteria (best) or expert opinion (second best), same diagnosis performed on whole sample, diagnosis
independent of MRI, diagnosis blinded for MRI, and reproducibility of diagnosis tested (inter- and intraexaminer reliability tested and reported). MRI evaluation
assessed on clear definition of each relevant MRI finding, MRI blinded from diagnosis, reproducibility (inter- and intraexaminer reliability tested and reported),
and short time between the MRI scan and diagnosis. Data analysis and presentation of results assessed on statistical significance test and confidence intervals
reported where relevant and results presented in an understandable way. 0, Nonacceptable; 1, Reasonable; 2, Good; SpA, spondyloarthritis; IBP, inflammatory
back pain.
PubMed n =1336 
Embase n = 2359 
Reviewed by title 
and abstract 
n=2395 
Full text articles 
reviewed 
n= 76 
Studies included in 
review  
Cross-sectional: 
n = 9 
Longitudinal: 
n = 0 
Excluded 
n =2319 
 
Excluded 
Cross-sectional: 
n = 48 
Longitudinal: 
n = 19 
High quality studies 
n = 2 
 
Duplicates 
n = 1300 
 
Figure 1 Flow chart of the review process.
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Table 2 Reasons for excluding retrieved articles on cross-sectional studies
Study Reasons for exclusion
Ahlstrom H, et al. (1990) [6] < 20 controls
Algin O, et al. (2009) [25] < 20 controls
Algin O, et al. (2010) [26] < 20 controls
Baraliakos X, et al. (2005) [27] No controls
Bejia I, et al. (2004) [28] < 20 cases
Blum U, et al. (1996) [29] Field strength, < 1.5 Tesla
Bochkova AG, et al. (2010) [30] No controls
Bollow M, et al. (1993) [31] Double publication on Bollow et al. [10]
Bollow M, et al. (1994) [32] Double publication on Bollow et al. [10]
Bozgeyik Z, et al. (2008) [33] No controls
Braun J, et al. (1994) [34] < 20 controls
Braun J, et al. (1998) [35] Reference standard (HLA-B27 status) not a clinical diagnosis
Bredella MA, et al. (2006) [36] No controls
Chung H Y, et al. (2011) [37] No controls
Docherty P, et al. (1992) [38] < 20 controls
Friedburg H, et al. (1987) [39] No controls
Gleeson TG, et al. (2005) [40] < 20 cases
Gupta AD, et al. (2009) [41] < 20 controls
Hanly JGJ, et al. (1994) [42] < 20 controls
Heuft-Dorenbosch L, et al. (2006) [43] Reference standard (plain radiographic) not a clinical diagnosis
Heuft-Dorenbosch L, et al. (2006) [44] No controls
Heuft-Dorenbosch L, et al. (2007) [45] No controls
Inanc N, et al. (2005) [46] Reference standard (plain radiographic) not a clinical diagnosis
Jevtic V, et al. (1996) [47] No controls
Liao Z, et al. (2009) [48] No MRI of the control group
Liao Z, et al. (2011) [49] No controls
Luukkainen RK, et al. (2007) [50] No controls
Marc V, et al. (1997) [51] < 20 controls
McNally EG, et al. (2001) [52] < 20 cases
Muche B, et al. (2003) [53] No controls
Murphey MD, et al. (1991) [54] < 20 controls
Orchard TR, et al. (2009) [55] < 20 cases
Peterova V et al. (2006) [56] No controls
Puhakka KB, et al. (2003) [57] No controls
Remy, et al. (1996) [58] No controls
Rennie WJ, et al. (2009) [59] < 20 controls
Rudwaleit M, et al. (2009) [60] < 20 controls
Rudwaleit M, et al. (2009) [8] Insufficient result presentation
Rudwaleit M, et al. (2009) [61] Insufficient result presentation
Sreedhar C, et al. (2006) [62] < 20 cases
Weber U, et al. (2007) [63] < 20 controls
Weber U, et al. (2010) [64] Double publication on Weber et al. [13]
Wecbach et al. (2009) [65] No controls
Wienands K, et al. (1990) [66] No controls
Williamson L, et al. (2004) [67] Reference standard (orthopedic test) not a clinical diagnosis
Wittram C, et al. (1996) [68] < 20 controls
Wittram C, et al. (1996) [69] < 20 controls
Yu W, et al. (1998) [70] < 20 controls
Studies may have met exclusion criteria other than those listed in the table. MRI, magnetic resonance imaging.
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unknown origin [10,12-15,17,18]. For further details of the
included studies, see Table 4.
All studies used an MRI scanner with a field strength
of 1.5 Tesla. Four of the included articles had no
description of the field strength, and the corresponding
authors were therefore contacted for information of the
field strength. Eight of the nine articles reported which
MRI protocol was used [10,11,13-18]. For the SIJ, the
most common sequences were T1-weighted spin-echo in
combination with either a gadolinium sequence
[10,11,14] or a Short Tau Inversion Recovery (STIR)
sequence [13]. The slice orientation was either semicor-
onal or semiaxial or a combination of both. In the
spine, the MRI protocol consisted of fewer sequences.
Three articles reported the use of sagittal T1-weighted
spin-echo and STIR [15,17,18], and one used only sagit-
tal STIR [16]. None of the included studies evaluating
the spine used contrast enhancement in the MRI proto-
col. For more details of the MRI protocols, see Table 5.
Assessment of methodologic quality
The quality score of the nine studies ranged from 1 to 7
points, with a mean score of 3.7. Two articles were
rated more than 5 points and were considered of high
quality [13,16], and three articles were rated less than 3
points [10-12] (Table 1).
In relation to the description of the study samples, five
articles did not fully describe both cases and noncases
with respect to age, gender, and diagnosis [11,14,15,17,18],
three articles had no description of the sampling method
used for the control groups [11,17,18], and for two of
these [17,18], it was not clear whether these groups were
included in the data analyses. Regarding the sampling
Table 3 Reasons for excluding retrieved articles on
longitudinal studies
Study Reasons for exclusion
Althoff CE, et al. (2009) [71] Insufficient result presentation
Aydin SZ, et al (2011) [72] < 20 controls
Baraliakos X, et al. (2008) [73] No controls
Battafarano DF, et al. (1993) [74] < 20 controls
Bennett AN, et al. (2008) [7] No controls
Bigot J, et al. (1999) [75] < 20 control
Brandt J, et al. (1999) [76] No controls
Chiowchanwisawakit P, et al. (2011) [77] No controls
Dougados M, et al. (2001) [78] Insufficient result presentation
Hermann J, et al. (2009) [79] Insufficient result presentation
Madsen K, et al. (2010) [80] No controls
Macsymowych WP, et al. (2010) [81] No controls
Marzo-Ortega H, et al. (2008) [82] < 20 in each control group
Oostveen J, et al. (1999) [83] No controls
Pedersen SJ, et al. (2011) [84] No controls
Puhakka KB, et al. (2004) [85] No controls
Remplik P, et al. (2005) [86] < 20 cases
Shankar S, et al. (2009) [87] Insufficient result presentation
Song IH, et al. (2011) [88] No controls
Studies may have met exclusion criteria other than those listed in the table.
Table 4 Descriptive data for articles on MRI and SpA fulfilling the inclusion criteria
Study type Total
number
Number of AS
patients (DD)
Number of SpA
patients (DD)
Number of IBP
patients (DD)
Number of NILBP
patients (DD)
Number of no
LBP patients
Sacroiliac
joint
Bollow et al.
(1995) [10]
Prospective
case-control
125 36 (3.1 years) 36 (5.9 years) 53 (5.7 years)
Klauser et al.
(2004) [11]
Prospective
case-control
133 103 (NR) 30
Brandt et al.
(2007) [12]
Prospective
cohort
158 32 (NR) 58 (NR) 68 (NR)
Weber et al.
(2010) [13]
Prospective
case-control
187 75 (6.1 years) 27 (29 mo) 26 (NR) 59
Wick et al.
(2010) [14]
Retrospective
cohort
156 27 (NR) 101 (NR) 28 (NR)
Spine
Kim et al.
(2008) [15]
Retrospective
case control
104 52 (NR) 52 (NR)
Weber et al.
(2009) [16]
Prospective
case-control
85 35 (8 years) 25 (10 mo) 35
Bennett et al.
(2009) [17]
Retrospective
cohort
185 64 (8.5 years) 110 (NR) 11
Bennett et al.
(2009) [18]
Retrospective
cohort
185 64 (8.5 years) 110 (NR) 11
MRI, magnetic resonance imaging; SpA, spondyloarthritis; AS, ankylosing spondylitis; DD, mean disease duration;
IBP, inflammatory back pain; NILBP, noninflammatory low-back pain; no LBP, no low-back pain; mo, months; NR, mean disease duration not reported.
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methods used, one article reported the use of consecutive
sampling [16]. The remaining eight either failed to report
on this aspect or used convenience samples. Matching was
performed adequately in relation to age and sex in four
[10,13,15,16] of the five case-control studies. One study
had a case group with a mean age that was more than 20
years older than that of the control group [11].
In relation to the diagnosis of the target condition,
none of the nine articles tested the reproducibility of the
clinical diagnosis. Diagnostic criteria were used as a refer-
ence standard in five articles [10,11,13,15,16], expert opi-
nion in three articles [14,17,18], and both criteria and
expert opinion in one article [12]. In four articles describ-
ing retrospective studies [14,15,17,18], the independence
of MRI from the clinical diagnosis was unclear. In one
prospective study [12], which aimed to test referral
recommendations, MRI was recognized as part of the
diagnosis for the group of preradiographic SpA, thereby
confounding the association observed. In seven articles
[10-12,14,15,17,18], inadequate or no reporting was made
of blinding of the MRI results at the time of the clinical
diagnosis.
In relation to the MRI evaluation, most studies had
acceptable definitions of the MRI findings [13-18]. Five
articles performed reproducibility tests of the MRI eva-
luation [13,14,16-18], and five studies blinded the eva-
luation for the diagnosis [13-17]. None of the nine
articles reported the time interval between MRI and
diagnosis.
In relation to the statistical analysis, one article failed
to report fully the CI, P values, and/or raw data [10],
and one article used an inappropriate statistical method
for the types of data available [14]. Five articles had
shortcomings in the way the results were presented
[10,12,14,17,18], such as uncertainties in relation to
which groups were included in the calculation of the
specificity [17,18] and data primarily presented as gra-
phics and per SIJ joint instead of per person [10].
Association between MRI findings and the clinical
diagnosis of SpA
Because of a substantial heterogeneity in the included
studies regarding the methodologic quality, the MRI find-
ings, the MRI technique used, and the regions under eva-
luation, it was not possible to perform a meta-analysis,
and we decided not to report data systematically. Instead,
a descriptive assessment of the results based on the
extracted data was performed. One article of high quality
was found that evaluated the SIJ [13], and another article
of high quality was found that evaluated the spine [16],
both of which were from the same research team. A sum-
mary of the extracted data from these two studies is pre-
sented in Tables 6 and 7.
Sacroiliac joint
The study by Weber et al. from 2010 [13] included four
groups in a prospective case-control study: 75 patients
with AS included on the basis of the modified New
York criteria [19], 27 patients with IBP based on the
Table 5 Descriptive data for MRI technique used in the included articles
Field
strength
Sequence
1
Sequence 2 Sequence 3 Sequence 4 Sequence 5 Sequence 6
Sacroiliac joint
Bollow et al.
(1995) [10]
1.5 T Semi axial
T1w SE
Dynamic T2*w
GRE, FLASH,
Dynamic T2*w GRE,
FLASH, Gd
Klauser et al.
(2004) [11]
1.5 T Semi axial
T1w, SE
Semi axial T2 w
TSE
Semi axial T1w, SE
FS
Semi cor. T1w, SE Semi cor. TIRM Semi axial + Semi cor.
T1w, SE, FS, Gd
Brandt et al.
(2007) [12]
a1.5 T NR
Weber et al.
(2010) [13]
a1.5 T Semi cor.
T1 w, SE
Semi cor. STIR
Wick et al.
(2010) [14]
1.5 T Semi cor.
T1 w, SE
Semi cor. TIRM Semi cor. T2w,
MEDIC FS
Semi cor. + semi
axial T1w, SE, FS
Semi axial T1w,
SE, FS, Gd
Semi axial T1w, SE, Gd
Spine
Kim et al.
(2008) [15]
1.5 T Sagittal T1w
SE
Sagittal T2w FSE
Weber et al.
(2009) [16]
1.5 T Sagittal
turbo STIR
Bennett et al.
(2009) [17]
a1.5 T Sagittal T1,
SE
Sagittal STIR
Bennett et al.
(2009) [18]
a1.5T Sagittal
T1w, SE
Sagittal STIR
aInformation on field strength not available in the articles. Data obtained by personal contact with authors. T, Tesla; w, weighted; SE, spin-echo; GRE, gradient-
echo; FLASH, fast low-angle shot; Semi cor, semicoronal; Gd, gadolinium; TSE, turbo spin-echo; FS, fat saturated; TRIM, turbo inversion recovery magnitude; NR,
not reported; STIR, short tau inversion recovery; MEDIC, multi echo data image combination; PD, proton density; FSE, fast spin echo.
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Table 6 Associations between MRI finding in the SIJ and the diagnosis of AS and IBP
MRI findings Sensitivity of MRI findings
(95% CI)
Specificity of MRI findings
(95% CI)
Cases, number Controls, number
AS IBP NLSBP No LBP
BMO 0.85 (0.76-0.92) 0.93 (0.84-0.97) 75 59
Erosions 0.91 (0.82-0.95) 0.98 (0.91-1.00) 75 59
Fat infiltration 0.91 (0.82-0.95) 0.86 (0.76-0.93) 75 59
Ankylosis 0.27 (0.18-0.38) 1.00 (0.94-1.00) 75 59
Global assessment 0.99 0.96 75 59
BMO 0.85 (0.76-0.92) 0.77 (0.58-0.89) 75 26
Erosions 0.91 (0.82-0.95) 0.96 (0.81-0.99) 75 26
Fat infiltration 0.91 (0.82-0.95) 0.85 (0.67-0.94) 75 26
Ankylosis 0.26 (0.18-0.38) 1.00 (0.87-1.00) 75 26
Global assessment 0.99 0.92 75 26
BMO 0.67 (0.48-0.81) 0.93 (0.84-0.97) 27 59
Erosions 0.48 (0.31-0.66) 0.98 (0.91-1.00) 27 59
Fat infiltration 0.37 (0.22-0.56) 0.86 (0.76-0.93) 27 59
Global assessment 0.52 0.96 27 59
BMO 0.67 (0.48-0.81) 0.77 (0.58-0.89) 27 26
Erosions 0.48 (0.31-0.66) 0.96 (0.81-0.99) 27 26
Fat infiltration 0.37 (0.22-0.56) 0.85 (0.67-0.94) 27 26
Global assessment 0.52 0.92 27 26
Results from Weber et al. (2010). Sensitivity and specificity based on concordant observations of a minimum of two of five readers. 95% CI calculated from raw
data. MRI, magnetic resonance imaging; SIJ, sacroiliac joint; AS, ankylosing spondylitis; IBP, inflammatory back pain; CI, confidence interval; NSLBP, nonspecific
low-back pain; BMO, bone marrow edema; global assessments, 95% CI not possible to calculate, because of no raw data.
Table 7 Associations between MRI finding in the spine and the diagnosis of AS and IBP
MRI findings Sensitivity of MRI findings
(95% CI)
Specificity of MRI findings
(95% CI)
Cases, number Controls, number
AS IBP No LBP
≥ 1 CIL 0.77 (0.61-0.88) 0.77 (0.61-0.88) 35 35
≥ 2 CIL 0.69 (0.52-0.81) 0.94 (0.81-0.98) 35 35
≥ 3 CIL 0.66 (0.49-0.79) 0.94 (0.81-0.98) 35 35
≥ 1 tCIL 0.69 (0.52-0.81) 0.83 (0.67-0.92) 35 35
≥ 2 tCIL 0.57 (0.41-0.72) 0.94 (0.81-0.98) 35 35
≥ 3 tCIL 0.46 (0.30-0.62) 0.97 (0.85-0.99) 35 35
≥ 1 lCIL 0.51 (0.36-0.67) 0.94 (0.81-0.98) 35 35
≥ 1 NIL 0.06 (0.02-0.19) 0.97 (0.85-0.99) 35 35
≥ 1 LIL 0.31 (0.19-0.48) 0.97 (0.85-0.99) 35 35
≥ 1 FIL/PIL 0.09 (0.03-0.22) 1.00 (0.90-1.00) 35 35
≥ 1 CIL 0.40 (0.23-0.59) 0.88 (0.70-0.96) 25 25
≥ 2 CIL 0.32 (0.17-0.52) 0.96 (0.80-0.99) 25 25
≥ 3 CIL 0.12 (0.04-0.30) 0.96 (0.80-0.99) 25 25
≥ 1 tCIL 0.32 (0.17-0.52) 0.88 (0.70-0.96) 25 25
≥ 2 tCIL 0.24 (0.11-0.43) 0.96 (0.80-0.99) 25 25
≥ 3 tCIL 0.12 (0.04-0.30) 0.96 (0.80-0.99) 25 25
≥ 1 lCIL 0.24 (0.11-0.43) 1.00 (0.87-1.00) 25 25
≥ 1 NIL 0.04 (0.01-0.20) 0.96 (0.80-0.99) 25 25
≥ 1 lCIL 0.12 (0.04-0.30) 0.96 (0.80-0.99) 25 25
≥ 1 FIL/PIL 0.00 (0.00-0.13) 1.00 (0.87-1.00) 25 25
Sensitivity and specificity based on concordant observations of three readers; results from Weber et al. (2009). AS, Ankylosing spondylitis; IBP, inflammatory back
pain; no LBP, no low-back pain; CIL, vertebral corner inflammatory lesion; tCIL, thoracic CIL; lCIL lumbar CIL; NIL, vertebral noncorner inflammatory lesion; LIL,
lateral inflammatory lesion; FIL/PIL, facet or other posterior element inflammatory lesion.
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Calin Criteria [20] or the Berlin Criteria [21], 26 patients
with NSLBP, and 59 healthy controls without back pain.
The AS patients had a mean disease duration of 6.1
years, and IBP patients had a mean disease duration of
29 months. Disease duration for the NSLBP patients
was not reported.
The MRI findings under evaluation were bone marrow
edema (BMO), erosions, fat infiltration, global assess-
ment of sacroiliitis, and ankylosis. Positive associations
for BMO, erosions, fat infiltration, and global assess-
ment of sacroiliitis were shown for both AS and IBP
patients when compared with the NSLBP and no-LBP
groups. Ankylosis was found in only the AS patients, in
20 of 75 patients (26.7%). In general, the highest com-
bined values of sensitivity and specificity were found
when comparing AS patients with the healthy controls,
and the lowest values were found when comparing IBP
with NSLBP (Table 6).
Interestingly, BMO lesions, as defined in the ASAS
diagnostic criteria [8], were found to be relatively fre-
quent in NSLBP and were reported in 6 (23.1%) of 26
subjects and less frequently in healthy controls, with 4
(6.8%) of 59 subjects.
Spine
The study by Weber et al. from 2009 [16] compared 35
patients with AS fulfilling the modified New York criteria
[19], 25 patients with IBP, who fulfilled the Berlin criteria
[21] and who also had one or more characteristic SpA
features, and 35 healthy controls without back pain in a
prospective case-control study. The AS patients had a
mean disease duration of 8.0 years and the IBP patients
had a mean disease duration of 10 months.
The MRI findings under evaluation were BMO lesions
of varied number and location in the spine. When com-
paring AS patients with healthy controls, a number of
positive associations were identified for BMO lesions in
vertebral corners and in the lateral spine. When compar-
ing IBP patients with healthy controls, the associations
were seen to decrease (see Table 7 for details).
Discussion
Summary of main results
The results of the review show that a positive association
exists between certain MRI findings in the axial skeleton
and the diagnosis of both AS and IBP. However, these
results are based on only two high-quality studies, and
the amount of relevant data was insufficient to give a reli-
able quantification of this association.
Implications for research
On the basis of the identified methodologic shortcomings
of the included articles, this review highlights important
issues that should be taken into consideration when con-
ducting studies with the aim of evaluating the diagnostic
utility of MRI in the diagnosis of SpA. The following
issues will be discussed in the subsequent text: Size of
the study sample, selecting the proper study population,
sampling method of the study cohort, independence of
MRI from the reference standard, reproducibility testing
of both the reference standard and the MRI evaluation,
and standardization of the MRI findings.
In this review, the inclusion criterion for the size of
study samples was set to a minimum of 20 subjects per
group. This was because a small sample size often gives
imprecise estimates of diagnostic accuracy. For example,
when the number of patients with SpA is 20, the two-
sided 95% CI of a sensitivity of 80% is 58% to 92%. This
is, however, still a very wide CI, and because wide CIs
make it difficult to determine how informative the
results of the study are, we would recommend that
future studies use larger sample size. For example, if the
number of patients with SpA is 200, the two-sided 95%
CI of a sensitivity of 80% is 74% to 85%.
When choosing the study sample, it is crucial that an
effort be made to make it as comparable to the popula-
tion seen in a clinical setting as possible. Not surprisingly,
the results from the two high-quality studies show that
the association was stronger between patients with AS
and asymptomatic people than the association between
IBP patients and patients with NSLBP [13,16]. However,
for the clinician, the challenge will often be differentiat-
ing between IBP and NSLBP. When investigating the
diagnostic utility of MRI in SpA, it is therefore important
that the study samples be representative of “real” patient
populations, instead of comparing patients with long-
lasting disease and asymptomatic persons. Furthermore,
one of the high-quality studies reports inflammatory MRI
findings in the SIJ to be relatively common in patients
with NSLBP [13]. Because the specificity is estimated
entirely from results from the group of noncases or con-
trols, this, additionally, underlines the need for further
evaluation of the presence of MRI findings also in
patients with NSLBP.
The sampling methods used in the included studies were
either insufficient or not fully described in the majority of
the studies, which makes it difficult to preclude selection
bias. It is mandatory when conducting studies on diagnos-
tic accuracy that both the sampling method and the study
sample are well described, that the selection of study parti-
cipants is performed systematically and unselectively, and,
for case-control studies, that the two groups are compar-
able except for the target condition. Furthermore, in some
of the articles identified in this review, the importance of
the controls seemed to be underestimated, even though
the sampling and description of the controls are just as
important as the sampling and description of the cases.
That no objective gold standard exists for the diagno-
sis of SpA, which is instead based on a composite
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clinical presentation, constrains the possibilities for the
evaluation of the diagnostic accuracy of MRI. However,
it is indisputable that when evaluating a diagnostic test,
independent evaluation of the index test and the refer-
ence standard is essential. When MRI is used in the
decision making of the clinical diagnosis, as seen in
more than half of the included studies, incorporation
bias is highly likely. This was predominantly a problem
in the included retrospective studies. The fact that MRI
is widely used in the diagnosis of SpA restricts the pos-
sibilities of conducting meaningful retrospective studies
on the diagnostic accuracy of MRI.
One way to strengthen the reliability of the diagnosis is
to test the reproducibility of the selected reference stan-
dard. However, none of the nine included articles tested
the reproducibility of the clinical diagnosis. Another way
to strengthen the reliability of the diagnosis would be to
include a longitudinal aspect and to follow the develop-
ment of more-advanced disease stages to confirm the diag-
nosis. Even though several longitudinal studies were
identified in this review, none met the inclusion criteria,
usually because either no or too few controls were used.
Several activity scores for inflammatory and structural
MRI findings have been developed; however, no interna-
tional consensus exists about the definition of diagnostic
MRI findings, which was a factor in our review. In general,
the included studies contained definitions of the MRI find-
ings. However, little homogeneity existed in these defini-
tions, and only five of the nine articles reported testing of
the reproducibility of the MRI evaluation. Before testing
the diagnostic utility of an MRI finding, it is necessary to
define the MRI finding and further to present acceptably
reproducible test results. Furthermore, an experienced
musculoskeletal radiologist should be part of the conduct
and testing of the evaluation protocol. An international
agreement on definitions of different MRI findings and a
threshold minimal reproducibility would facilitate both the
translation from research to clinical practice and a com-
parison with future research results.
In summary, the optimal design for future studies that
investigate the utility of MRI in the early diagnosis of
SpA is a large longitudinal clinical cohort study that
recruits participants consecutively and includes patients
with NSLBP. Furthermore, a well-defined clinical diag-
nosis based on consensus criteria and blinded for MRI
should be used as a reference standard. Similarly, a vali-
dated MRI evaluation with clear definitions blinded to
the clinical information should be used for the MRI
evaluation.
Application of findings to clinical practice
The literature search associated with the current review
revealed no other systematic critical review on the utility
of MRI in the diagnosis of SpA. However, a large
number of commentaries and narrative reviews with or
without transparent search strategies have been pub-
lished, in which it seems that the majority report a posi-
tive view of the value of MRI in the diagnosis of SpA.
The obvious need for optimization of the diagnostic
process of SpA may have contributed to the positive
perception that has developed regarding MRI as a tool
in the SpA diagnosis. The fact that MRI of the SIJ is
included in the new diagnostic criteria developed by
ASAS [8] has led to further optimism in relation to the
diagnostic process of SpA. However, on the basis of the
results from the current review, the limited number of
high-quality studies on the diagnostic utility of MRI in
SpA should preclude MRI being seen as the new gold
standard in the diagnosis of SpA. If inflammatory and
structural MRI findings are interpreted as being more
specific for SpA than the research can support, a real
risk exists of SpA being overdiagnosed.
As mentioned earlier, to be able to make a reasonable
translation of research results to clinical practice, the
representativeness of the study sample to clinical practice
and the standardization and validation of the MRI eva-
luation is important. However, it also is essential that the
MRI protocols used in the studies are relatively easy to
implement and constitute the least health risk for the
patients. Three of the studies included in this review
used gadolinium contrast-enhanced sequences. However,
for future studies, the necessity of gadolinium should be
carefully considered, because other techniques, such as
STIR, have shown a similar capability of visualizing BMO
[22,23], and the use of contrast is more invasive, expen-
sive, and time consuming than is a noncontrast method.
Furthermore, a small but serious risk of contrast med-
ium-induced nephrotoxicity exists [24], which also must
be taken into consideration.
Strengths and weaknesses of the review
The strength of the current review is the systematic
search method and the rigorous assessment of the
methodologic quality of the included studies. To our
knowledge, this review is the first to give an overview of
the level of evidence of the diagnostic utility of MRI,
including a quality assessment.
The weaknesses of the review are first, the possibility
of relevant articles not being included because of the
language limitations, and second, the limited number of
databases used in the search. Furthermore, it might be
argued that the threshold for a minimal study sample
size was either too low or too high. However, it seems
reasonable to reduce the width of the 95% CI by not
setting the cut-point too low; in contrast, increasing the
cut-point for sample size further would have greatly
decreased the number of relevant articles that could be
included.
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Conclusion
Bone marrow edema, erosions, fat infiltrations, global
assessment of sacroiliitis, and ankylosis on MRI were
found to be associated with SpA. However, because
only two high-quality studies were identified, it was
not possible to perform a meta-analytic quantification
of the association. The current systematic critical
review illustrates that only limited evidence exists of
the utility of MRI in the diagnosis of SpA. However,
MRI is already widely used in clinical practice, and
therefore, a strong need exists for more high-quality
studies, cross-sectional as well as longitudinal, without
the shortcomings of the previous work identified in
this review. In the meantime, caution is needed to
avoid overdiagnosing SpA.
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